Live Breaking News & Updates on Yves Gaudin

Stay updated with breaking news from Yves gaudin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Concern over vaccine effectiveness on variants


Concern over vaccine effectiveness on variants
Updated / Sunday, 9 May 2021
11:07
Health workers in a temporarily converted Covid-19 ward in New Delhi
A Covid-19 variant spreading in India is more contagious and may be dodging vaccine protections, contributing to the country s explosive outbreak, the World Health Organization s chief scientist has said.
In an interview with AFP, Soumya Swaminathan warned that the epidemiological features that we see in India today do indicate that it s an extremely rapidly spreading variant .
India registered more than 4,000 Covid-19 deaths in just 24 hours for the first time yesterday, and more than 400,000 new infections.
New Delhi has struggled to contain the outbreak, which has overwhelmed its healthcare system, and many experts suspect the official death and case numbers are a gross underestimate. ....

United States , United Kingdom , New Delhi , Alexis Peyroles , Yves Gaudin , Narendra Modi , Soumya Swaminathan , Albert Bourla , Julian Tang , World Health Organization , Prime Minister Narendra Modi , Lyon Based Osivax , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , புதியது டெல்ஹி , ஐவ் காடின் , நரேந்திர மோடி , சௌமிய சுவாமிநாதன் , ஜூலியன் டாங் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ப்ரைம் அமைச்சர் நரேந்திர மோடி ,

Covid-19 - Vers des vaccins tout-terrain face aux mutations du virus

Covid-19 - Vers des vaccins tout-terrain face aux mutations du virus
20min.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 20min.ch Daily Mail and Mail on Sunday newspapers.

Afp Alexis , Yves Gaudin , World Health , Published May , British Afp , French Afp , ஐவ் காடின் , உலகம் ஆரோக்கியம் , வெளியிடப்பட்டது இருக்கலாம் ,

In fight against COVID-19 variants, some firms target T cell jabs


Published May 8, 2021 2:46pm
Getting Covid vaccines into the arms of the world s population is an international priority but will today s jabs stay effective against virus variants that are spreading across the globe?
It is one of the big questions about the pandemic, with Pfizer chief Albert Bourla recently acknowledging that it is likely a booster will be needed to help extend the protection conferred by its vaccine and ward off new variants.
A recent study presented a mixed picture. 
It found that the antibody response of current vaccines could fail against variants. However, a second immune response in the form of killer T cells which attack already infected cells and not the virus itself remained largely intact. ....

United States , United Kingdom , Alexis Peyroles , Yves Gaudin , Albert Bourla , Julian Tang , World Health Organization , Getting Covid , Lyon Based Osivax , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஐவ் காடின் , ஜூலியன் டாங் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,

In fight against Covid variants some firms target T cell jabs


In fight against Covid variants some firms target T cell jabs
Issued on:
08/05/2021 - 07:39
Some researchers are looking at targeting T cells instead of antibodies to create a wider immune response better able to tackle coronavirus variants Christophe ARCHAMBAULT AFP
3 min
Paris (AFP)
Getting Covid vaccines into the arms of the world s population is an international priority but will today s jabs stay effective against virus variants that are spreading across the globe?
It is one of the big questions about the pandemic, with Pfizer chief Albert Bourla recently acknowledging that it is likely a booster will be needed to help extend the protection conferred by its vaccine and ward off new variants. ....

United States , France General , United Kingdom , Alexis Peyroles , Yves Gaudin , Albert Bourla , Julian Tang , World Health Organization , Lyon Based Osivax , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , ஐவ் காடின் , ஜூலியன் டாங் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,

Some firms target T cell jabs in fight against Covid variants


Some firms target T cell jabs in fight against Covid variants
SECTIONS
Last Updated: May 08, 2021, 11:40 AM IST
Share
Synopsis
It found that the antibody response of current vaccines could fail against variants. However, a second immune response in the form of killer T cells which attack already infected cells and not the virus itself remained largely intact.
iStock
Getting Covid vaccines into the arms of the world s population is an international priority but will today s jabs stay effective against virus variants that are spreading across the globe?
It is one of the big questions about the pandemic, with ....

United States , United Kingdom , Alexis Peyroles , Yves Gaudin , Albert Bourla , Julian Tang , World Health Organization , Getting Covid , Lyon Based Osivax , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஐவ் காடின் , ஜூலியன் டாங் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,